DK0946567T3 - Hidtil ukendte camptothecinanaloge forbindelser, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem - Google Patents

Hidtil ukendte camptothecinanaloge forbindelser, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem

Info

Publication number
DK0946567T3
DK0946567T3 DK97950236T DK97950236T DK0946567T3 DK 0946567 T3 DK0946567 T3 DK 0946567T3 DK 97950236 T DK97950236 T DK 97950236T DK 97950236 T DK97950236 T DK 97950236T DK 0946567 T3 DK0946567 T3 DK 0946567T3
Authority
DK
Denmark
Prior art keywords
drugs
analog compounds
pharmaceuticals containing
camptothecin analog
new camptothecin
Prior art date
Application number
DK97950236T
Other languages
Danish (da)
English (en)
Inventor
Dennis Bigg
Olivier Lavergne
Rodas Francesc Pla
Jacques Pommier
Gerard Ulibarri
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK0946567T3 publication Critical patent/DK0946567T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK97950236T 1996-12-20 1997-12-05 Hidtil ukendte camptothecinanaloge forbindelser, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem DK0946567T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615774A FR2757514B1 (fr) 1996-12-20 1996-12-20 Nouveaux analogues de la camptothecine, des procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
PCT/FR1997/002218 WO1998028305A1 (fr) 1996-12-20 1997-12-05 Nouveaux analogues de la camptothecine, leur application comme medicaments et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DK0946567T3 true DK0946567T3 (da) 2003-12-22

Family

ID=9498938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97950236T DK0946567T3 (da) 1996-12-20 1997-12-05 Hidtil ukendte camptothecinanaloge forbindelser, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem

Country Status (25)

Country Link
EP (1) EP0946567B1 (cs)
JP (2) JP3576175B2 (cs)
KR (1) KR100516874B1 (cs)
CN (1) CN1097056C (cs)
AR (1) AR008543A1 (cs)
AT (1) ATE248177T1 (cs)
AU (1) AU734485B2 (cs)
BR (1) BR9714170A (cs)
CA (1) CA2275351C (cs)
CZ (1) CZ299795B6 (cs)
DE (1) DE69724453T2 (cs)
DK (1) DK0946567T3 (cs)
ES (1) ES2206761T3 (cs)
FR (1) FR2757514B1 (cs)
HU (1) HUP9904210A3 (cs)
MX (1) MXPA99005776A (cs)
MY (1) MY119473A (cs)
NO (1) NO326464B1 (cs)
NZ (1) NZ335939A (cs)
PL (1) PL188181B1 (cs)
PT (1) PT946567E (cs)
RU (1) RU2194051C2 (cs)
UA (1) UA57758C2 (cs)
WO (1) WO1998028305A1 (cs)
ZA (1) ZA9711129B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2768431B1 (fr) * 1997-08-29 2000-03-24 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine, nouvel intermediaire de synthese optiquement pur et son procede de preparation
FR2790261B1 (fr) 1999-02-26 2004-09-10 Sod Conseils Rech Applic Nouveaux analogues optiquement purs de la camptothecine et leurs procedes de preparation
US6291676B1 (en) * 1999-03-03 2001-09-18 University Of Kentucky Research Foundation Water-soluble derivatives of camptothecin/homocamptothecin
US6207832B1 (en) * 1999-04-09 2001-03-27 University Of Pittsburgh Camptothecin analogs and methods of preparation thereof
AU3455100A (en) * 1999-05-28 2000-12-18 Nippon Chemiphar Co. Ltd. Process for the preparation of 2-halo-3-(3-quinolyl)propionic acid derivatives
US6372906B1 (en) 2001-04-12 2002-04-16 University Of Pittsburgh Synthesis of silyl camptothecins and silyl homocamptothecins
US6723853B2 (en) 2001-08-27 2004-04-20 University Of Pittsburgh Intermediates and methods of preparation of intermediates in the enantiomeric synthesis of (20R)homocamptothecins and the enantiomeric synthesis of (20R)homocamptothecins
AU2003225642A1 (en) * 2002-03-01 2003-09-16 Fluorous Techonologies Inc Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs
AR046579A1 (es) * 2003-11-12 2005-12-14 Smithkline Beecham Corp Compuesto cristalino de topotecan, composicion farmaceutica que lo comprende, procedimiento para prepararlo y su uso para preparar dicha composicion farmaceutica
ITRM20040288A1 (it) * 2004-06-11 2004-09-11 Sigma Tau Ind Farmaceuti Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero.
EP1794127A1 (en) * 2004-09-21 2007-06-13 Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) Novel processes for the production of useful intermediates
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
CN116514849B (zh) * 2022-01-28 2025-06-06 遵义医药高等专科学校 一种鬼臼毒素拼接奎宁衍生物及其应用
WO2023232145A1 (zh) * 2022-06-02 2023-12-07 华东师范大学 一种高喜树碱类小分子及其应用
WO2024230752A1 (zh) * 2023-05-08 2024-11-14 甘李药业股份有限公司 喜树碱衍生物、接头、配体-药物偶联物及其医药用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615547B2 (ja) * 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
US5391745A (en) * 1992-07-23 1995-02-21 Sloan-Kettering Institute For Cancer Research Methods of preparation of camptothecin analogs
AU716377B2 (en) * 1995-06-21 2000-02-24 Ipsen Pharma S.A.S. New analogues of camptothecin, preparation processes, their use as medicaments and the pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HUP9904210A3 (en) 2000-09-28
KR20000069608A (ko) 2000-11-25
AR008543A1 (es) 2000-01-19
CA2275351C (fr) 2008-10-14
FR2757514B1 (fr) 1999-02-12
ATE248177T1 (de) 2003-09-15
AU5326598A (en) 1998-07-17
KR100516874B1 (ko) 2005-09-26
PL334125A1 (en) 2000-02-14
DE69724453D1 (de) 2003-10-02
DE69724453T2 (de) 2004-06-09
PT946567E (pt) 2004-01-30
JP2001505922A (ja) 2001-05-08
PL188181B1 (pl) 2004-12-31
CN1097056C (zh) 2002-12-25
NZ335939A (en) 2000-04-28
CZ220599A3 (cs) 1999-09-15
EP0946567B1 (fr) 2003-08-27
HUP9904210A2 (hu) 2000-05-28
EP0946567A1 (fr) 1999-10-06
CN1241191A (zh) 2000-01-12
NO326464B1 (no) 2008-12-08
NO992998L (no) 1999-08-18
RU2194051C2 (ru) 2002-12-10
ES2206761T3 (es) 2004-05-16
JP2004115535A (ja) 2004-04-15
UA57758C2 (uk) 2003-07-15
JP3576175B2 (ja) 2004-10-13
HK1024695A1 (en) 2000-10-20
ZA9711129B (en) 1999-05-03
CA2275351A1 (fr) 1998-07-02
AU734485B2 (en) 2001-06-14
WO1998028305A1 (fr) 1998-07-02
MXPA99005776A (es) 2004-08-31
FR2757514A1 (fr) 1998-06-26
CZ299795B6 (cs) 2008-11-26
NO992998D0 (no) 1999-06-18
BR9714170A (pt) 2000-02-29
MY119473A (en) 2005-05-31

Similar Documents

Publication Publication Date Title
DK0835246T3 (da) Aromatiske forbindelser og farmaceutiske præparater, der indeholder dem
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
NO20002113L (no) Nye tricykliske forbindelser og deres anvendelse i medisin, fremgangsmÕte for deres fremstillling og farmasøytiske sammensetninger inneholdende dem
NO942835L (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
NO991815D0 (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO942834L (no) 1-benzensulfonyl-1,3-dihydro-indol-2-on-derivater, fremstilling derav, og farmasöytiske blandinger som inneholder dem
NO20001409L (no) Karboksamidotiazolderivater, fremgangsmÕte for fremstilling derav og farmasøytiske blandinger
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
DK0912613T3 (da) Syntetiske polysaccharider, fremgangsmåde til deres fremstilling og farmaceutiske præparater, der indeholder dem
DK1042323T3 (da) Hidtil ukendte tetracykliske camptothecin-analoge forbindelser, fremgangangsmåder til deres fremstilling, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
DK1095020T3 (da) 2-Aminopyridinderivater, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
IS2076B (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
DK1222163T3 (da) 2'-Substituerede 1,1'-biphenyl-2-carboxamider, fremgangsmåder til fremstilling deraf, deres anvendelse som medikament samt farmaceutiske præparater, som indeholder dem
DK0946567T3 (da) Hidtil ukendte camptothecinanaloge forbindelser, deres anvendelse som lægemidler og farmaceutiske præparater, der indeholder dem
NO923509D0 (no) N-substituerte heterocykliske forbindelser, fremstilling derav og farmasoeytiske blandinger som inneholder dem
DK1183256T3 (da) Puridinderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
DK0732328T3 (da) Heterocykliske, aromatiske forbindelser, farmaceutiske og kosmetiske sammensætninger, der indeholder dem, og anvendelser
DK1228039T3 (da) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater, der omfatter dem
NO983860D0 (no) Nye triazolopuriner, fremgangsmÕte for fremstilling av dem og deres anvendelse som legemidler
NO983472D0 (no) Taxoider, deres fremstilling og farmas°ytiske preparater inneholdende taxoidene
DK1210348T3 (da) Naphthyridinderivater, fremgangsmåde til deres fremstilling, deres anvendelse og farmaceutiske præparater omfattende dem
DK0986537T3 (da) Hidtil ukendte heteroethynylenforbindelser og farmaceutiske præparater og kosmetiske sammensætninger, der indeholder dem
DK1149832T3 (da) Benzamidderivater og lægemidler, der indeholder dem